BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24224112)

  • 1. Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis.
    Nordio M; Pajalich R
    J Thyroid Res; 2013; 2013():424163. PubMed ID: 24224112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with Myo-Inositol and Selenium Ensures Euthyroidism in Patients with Autoimmune Thyroiditis.
    Nordio M; Basciani S
    Int J Endocrinol; 2017; 2017():2549491. PubMed ID: 28293260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto's patients with subclinical hypothyroidism.
    Nordio M; Basciani S
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):51-59. PubMed ID: 28724185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression.
    Pace C; Tumino D; Russo M; Le Moli R; Naselli A; Borzì G; Malandrino P; Frasca F
    Endocr J; 2020 Nov; 67(11):1093-1098. PubMed ID: 32669509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin reduces autoimmune antibody levels in patients with Hashimoto's thyroiditis: A systematic review and meta-analysis.
    Jia X; Zhai T; Zhang JA
    Autoimmunity; 2020 Sep; 53(6):353-361. PubMed ID: 32741222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of selenium supplementation on antibodies of autoimmune thyroiditis].
    Zhu L; Bai X; Teng WP; Shan ZY; Wang WW; Fan CL; Wang H; Zhang HM
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(32):2256-60. PubMed ID: 23158484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hashimoto's thyroiditis: TGAb, TPOAb, TRAb and recovery from hypothyroidism.
    Takasu N; Yoshimura Noh J
    Expert Rev Clin Immunol; 2008 Mar; 4(2):221-37. PubMed ID: 20477052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study.
    Pirola I; Rotondi M; Cristiano A; Maffezzoni F; Pasquali D; Marini F; Coperchini F; Paganelli M; Apostoli P; Chiovato L; Ferlin A; Cappelli C
    Endocrinol Diabetes Nutr (Engl Ed); 2020 Jan; 67(1):28-35. PubMed ID: 31196739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation with myo-inositol and Selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism.
    Payer J; Jackuliak P; Kužma M; Džupon M; Vaňuga P
    Front Endocrinol (Lausanne); 2022; 13():1067029. PubMed ID: 36465640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenium supplementation could restore euthyroidism in subclinical hypothyroid patients with autoimmune thyroiditis.
    Pirola I; Gandossi E; Agosti B; Delbarba A; Cappelli C
    Endokrynol Pol; 2016; 67(6):567-571. PubMed ID: 28042649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis.
    Ferrari SM; Fallahi P; Di Bari F; Vita R; Benvenga S; Antonelli A
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):36-42. PubMed ID: 28724175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations.
    Gärtner R; Gasnier BC; Dietrich JW; Krebs B; Angstwurm MW
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1687-91. PubMed ID: 11932302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto's thyroiditis and hypothyroidism.
    Nourbakhsh M; Ahmadpour F; Chahardoli B; Malekpour-Dehkordi Z; Nourbakhsh M; Hosseini-Fard SR; Doustimotlagh A; Golestani A; Razzaghy-Azar M
    J Trace Elem Med Biol; 2016 Mar; 34():10-4. PubMed ID: 26854239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Inositol in Thyroid Physiology and in Subclinical Hypothyroidism Management.
    Benvenga S; Nordio M; Laganà AS; Unfer V
    Front Endocrinol (Lausanne); 2021; 12():662582. PubMed ID: 34040582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoinositol in Autoimmune Thyroiditis.
    Paparo SR; Ferrari SM; Patrizio A; Elia G; Ragusa F; Botrini C; Balestri E; Guarneri F; Benvenga S; Antonelli A; Fallahi P
    Front Endocrinol (Lausanne); 2022; 13():930756. PubMed ID: 35837308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis.
    Rieu M; Richard A; Rosilio M; Laplanche S; Ropion V; Fombeur JP; Berrod JL
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):529-35. PubMed ID: 8187321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of vitamin D on thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity in myo-inositol-treated and myo-inositol-naïve women with autoimmune thyroiditis: A pilot study.
    Krysiak R; Kowalcze K; Okopień B
    J Clin Pharm Ther; 2022 Nov; 47(11):1759-1767. PubMed ID: 35775148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between the Impairment of Endothelial Function and Thyroid Antibodies in Hashimoto's Thyroiditis Patients with Euthyroidism.
    Hu Y; Yao Z; Wang G
    Horm Metab Res; 2020 Sep; 52(9):642-646. PubMed ID: 32542626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myo-inositol in autoimmune thyroiditis, and hypothyroidism.
    Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Caruso C; Guglielmi G; Antonelli A
    Rev Endocr Metab Disord; 2018 Dec; 19(4):349-354. PubMed ID: 30506520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroglobulin Antibodies are Associated with Symptom Burden in Patients with Hashimoto's Thyroiditis: A Cross-Sectional Study.
    Barić A; Brčić L; Gračan S; Škrabić V; Brekalo M; Šimunac M; Lovrić VT; Anić I; Barbalić M; Zemunik T; Punda A; Boraska Perica V
    Immunol Invest; 2019 Feb; 48(2):198-209. PubMed ID: 30332318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.